BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RN5681 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RN5681\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07347678-1087@assetmemo.bio
DTSTAMP:20261121T005440Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:RN5681: Phase 1 readout est. (NCT07347678)
DESCRIPTION:RN5681\, phase 1\, Atherosclerotic Cardiovascular Disease.\nStu
 dy: Phase 1a Study to Evaluate the Safety\, Tolerability\, Pharmacokinetic
 s\, and Pharmacodynamics of RN5681 in Healthy Volunteers\nEstimated primar
 y completion: February 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/rn5681#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07347678
URL:https://assetmemo.bio/drug/rn5681#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
